Manufacturing Chemist Manufacturing Chemist
  • Home
  • Ingredients
  • Analysis
  • Manufacturing
  • Finance
  • Events
  • Directory
  • Regulatory
  • Drug Delivery
  • Research & Development
  • Sustainability

Actavis

www.actavis.com

Morris Corporate Center III
400 Interpace Parkway
Parsippany
New York
NJ 07054
United States

+1 862 261 7000

Activities

Manufacturing | Pharmaceutical

Related Companies

  • Romaco Holding GmbH
  • Titan Enterprises
  • TrakCel
  • Huber
  • GEA Pharma and Healthcare
  • Adare Pharma Solutions
  • Beamex
  • Burkert Fluid Control Systems
  • Envair Technology
  • Biopharma Group
  • Asynt
  • PCI Pharma Services
  • Watson Marlow Fluid Technology Solutions
  • Solvias
  • Labtex
  • Piramal Pharma Solutions
  • LB Bohle
  • Vetter Pharma International
  • Austar
  • PSL Powder Systems

Related Content

Pharma companies fined £45m for 'pay-for-delay'
Pharma companies fined £45m for 'pay-for-delay'
Schizophrenia – cariprazine
Schizophrenia – cariprazine
Amneal to purchase generics business of Actavis Australia
Amneal to purchase generics business of Actavis Australia
Actavis gets go-ahead from European Commission to purchase Allergan
Actavis gets go-ahead from European Commission to purchase Allergan
Actavis plans to change name to Allergan after acquisition closes
Actavis plans to change name to Allergan after acquisition closes
Actavis to divest Pharmatech to TPG
Actavis to divest Pharmatech to TPG
Nearly 90,000 Gabapentin capsules are recalled by Aurobindo Pharma and Actavis
Nearly 90,000 Gabapentin capsules are recalled by Aurobindo Pharma and Actavis
Actavis to buy Auden Mckenzie for £306m
Actavis to buy Auden Mckenzie for £306m
Actavis appoints Global Chief Compliance Officer
Actavis appoints Global Chief Compliance Officer
Actavis proposes senior leadership team after Allergan acquisition goes through
Actavis proposes senior leadership team after Allergan acquisition goes through
Actavis to buy Allergan for US$66bn
Actavis to buy Allergan for US$66bn
Actavis to buy Durata Therapeutics for US$675m
Actavis to buy Durata Therapeutics for US$675m
Actavis completes US$28bn purchase of Forest Laboratories
Actavis completes US$28bn purchase of Forest Laboratories
Actavis opens Asia Pacific regional headquarters in Singapore
Actavis opens Asia Pacific regional headquarters in Singapore
Actavis buys Thailand\'s Silom Medical for US$100m
Actavis buys Thailand\'s Silom Medical for US$100m
  • Advertise Subscribe
  • Terms & Conditions
  • Privacy Policy
  • Contact us at info@hpcimedia.com
Twitter LinkedIn RSS newsfeed
© HPCi Media Limited | Registered in England No. 6716035 | VAT GB 939828072 | a Claverley Group company